FOLH1 and prostate adenocarcinoma: At the end of 2018, he was diagnosed with prostate adenocarcinoma of the left lobe, Gleason 9 (4+5), with perineural permeation, staged as cT3aN1M0 using pelvic magnetic resonance imaging (MRI), prostate-specific membrane antigen (PSMA) PET scan, bone scintigraphy and thoraco-abdomino-pelvic computed tomography (CT).